Tiffin Carol, Broadhead Moira
Pract Midwife. 2015 Jan;18(1):23-5.
Since the 1980s epidural analgesia has been considered the gold standard for pain relief in labour. Over the past decade there has been a growing trend in UK maternity units to offer remifentanil PCA as a fast, safe alternative for women where epidural analgesia is contraindicated. Increasingly more obstetric units and anaesthetists are extending the use of remifentanil and in many units it is now preferred over central neuroaxial blocks (Stocki et al 2014). It would appear that remifentanil is being hailed as the panacea for labour pain. Whilst discussion around the use and effects of remifentanil is very well documented in anaesthetic journals, there is very little midwifery research around this subject. Following a review of the current evidence, this article will explore the use of remifentanil in labour, consequences for women and neonates and implications for midwifery practice.
自20世纪80年代以来，硬膜外镇痛一直被视为分娩镇痛的金标准。在过去十年中，英国产科病房有一种越来越明显的趋势，即对于硬膜外镇痛禁忌的女性，提供瑞芬太尼患者自控镇痛（PCA）作为一种快速、安全的替代方法。越来越多的产科单位和麻醉医生正在扩大瑞芬太尼的使用，在许多单位，它现在比中枢神经轴阻滞更受青睐（斯托基等人，2014年）。瑞芬太尼似乎被誉为治疗分娩疼痛的万灵药。虽然麻醉学杂志对瑞芬太尼的使用和效果有非常详尽的讨论，但关于这个主题的助产士研究却很少。在对当前证据进行综述之后，本文将探讨瑞芬太尼在分娩中的使用、对产妇和新生儿的影响以及对助产实践的意义。
